Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)
56.39
+2.68 (4.99%)
Apr 6, 2026, 3:28 PM IST
NSE:AAREYDRUGS Market Cap
NSE:AAREYDRUGS has a market cap or net worth of 1.62 billion as of April 6, 2026. Its market cap has increased by 53.85% in one year.
Market Cap
1.62B
Enterprise Value
2.10B
Revenue
3.91B
Ranking
n/a
PE Ratio
47.03
Stock Price
56.39
Market Cap Chart
Since April 17, 2007, NSE:AAREYDRUGS's market cap has increased from 147.01M to 1.62B, an increase of 998.79%. That is a compound annual growth rate of 13.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 1.62B | -14.92% |
| Dec 31, 2025 | 1.90B | 19.77% |
| Dec 31, 2024 | 1.59B | 23.59% |
| Dec 29, 2023 | 1.28B | 30.23% |
| Dec 30, 2022 | 984.93M | -9.47% |
| Dec 31, 2021 | 1.09B | 26.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 11.59B |
| Sigachi Industries | 7.41B |
| Valiant Laboratories | 3.10B |
| Bafna Pharmaceuticals | 2.62B |
| Nectar Lifesciences | 1.94B |
| Brooks Laboratories | 1.89B |
| Alpa Laboratories | 1.09B |
| Par Drugs and Chemicals | 1.05B |